ARDELYX, INC.

ARDX · Nasdaq · SIC 2834: Pharmaceutical Preparations
206
SEC Filings

Business Summary

PART I Overview We are a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. We currently market two therapies from the active ingredient tenapanor, a sodium/hydrogen exchanger (NHE3) inhibitor that was discovered and developed by Ardelyx. NHE3 is an antiporter expressed on the apical surface of the small and large intestines. Tenapanor is a minimally absorbed, first-in-class, oral, small m...

Next Earnings

Q2 FY2026 — expected 2026-08-10

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionARDXdiscussed_in_filing Cybersecurity
topic_mentionARDXdiscussed_in_filing Trusted Computing
topic_mentionARDXdiscussed_in_filing Blockchain & Crypto
topic_mentionARDXdiscussed_in_filing Regulation
topic_mentionARDXdiscussed_in_filing Healthcare & Bio
topic_mentionARDXdiscussed_in_filing Cybersecurity
topic_mentionARDXdiscussed_in_filing Trusted Computing
topic_mentionARDXdiscussed_in_filing Blockchain & Crypto
topic_mentionARDXdiscussed_in_filing Regulation
topic_mentionARDXdiscussed_in_filing Healthcare & Bio
topic_mentionARDXdiscussed_in_filing Cybersecurity
topic_mentionARDXdiscussed_in_filing Trusted Computing
topic_mentionARDXdiscussed_in_filing Blockchain & Crypto
topic_mentionARDXdiscussed_in_filing Regulation
topic_mentionARDXdiscussed_in_filing Healthcare & Bio
topic_mentionARDXdiscussed_in_filing Cybersecurity
topic_mentionARDXdiscussed_in_filing Trusted Computing
topic_mentionARDXdiscussed_in_filing Blockchain & Crypto
topic_mentionARDXdiscussed_in_filing Regulation
topic_mentionARDXdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-192025-12-310001437402-26-000013EDGAR75K words
2025-02-202024-12-310001628280-25-006653EDGAR—
2024-02-222023-12-310001628280-24-006393EDGAR—
2023-03-022022-12-310001628280-23-006041EDGAR—
2022-02-282021-12-310001628280-22-004226EDGAR—
2021-03-082020-12-310001558370-21-002500EDGAR—
2020-03-062019-12-310001558370-20-002138EDGAR—
2019-03-062018-12-310001558370-19-001583EDGAR—
2018-03-142017-12-310001558370-18-002056EDGAR—
2017-02-172016-12-310001193125-17-047972EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-10-302025-09-300001437402-25-000018EDGAR45K words
2025-08-042025-06-300001628280-25-037464EDGAR—
2025-05-012025-03-310001628280-25-021516EDGAR—
2024-10-312024-09-300001628280-24-044551EDGAR—
2024-08-012024-06-300001628280-24-034121EDGAR—
2024-05-022024-03-310001628280-24-019990EDGAR—
2023-10-312023-09-300001628280-23-035597EDGAR—
2023-08-022023-06-300001628280-23-026569EDGAR—
2023-05-032023-03-310001628280-23-015212EDGAR—
2022-11-032022-09-300001628280-22-028180EDGAR—
2022-08-042022-06-300001628280-22-021047EDGAR—
2022-05-052022-03-310001628280-22-012630EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-190001437402-26-000012EDGAR3K words
2026-01-080001437402-26-000003EDGAR—
2025-12-170001437402-25-000021EDGAR—
2025-10-300001437402-25-000016EDGAR—
2025-10-140001437402-25-000008EDGAR—
2025-08-040001628280-25-037441EDGAR—
2025-07-030001628280-25-034132EDGAR—
2025-06-180001628280-25-032172EDGAR—
2025-05-010001628280-25-021514EDGAR—
2025-04-290001628280-25-020477EDGAR—

206 total filings indexed. 174 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001437402
TickerARDX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 05671a7871635257d6fa69ef1673b26af1753f26e9647ba98c1b70938c850a2a
parent: 009c2b0fae57cbea3944b6ce32f77345dbcb561ed88340bb8222547a125449e3
content hash: 467e86ed342e48da21d0e2711626fd58d7a7e731b89470d776d1b0ba346575d7
signed: 2026-04-13T04:43:42.987Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf